USA flag logo/image

An Official Website of the United States Government

EVALUATION OF RETROVENOUS MYOCARDIAL DRUG DELIVERY SYSTEM

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
4973
Program Year/Program:
1988 / SBIR
Agency Tracking Number:
4973
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Utah Biomedical Test Labs
520 Wakara Way Salt Lake, UT 84108
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1988
Title: EVALUATION OF RETROVENOUS MYOCARDIAL DRUG DELIVERY SYSTEM
Agency: HHS
Contract: N/A
Award Amount: $484,000.00
 

Abstract:

THE FEASIBILITY OF RETROVENOUS MYOCARDIAL DRUG DELIVERY (XYLOCAINE) TO TREAT AND CONTROL ARRHYTHMIAS WILL BE TESTED IN SHEEP AFTER CORONARY ARTERY OCCULSION, AND THEN COMPARED TO THE STANDARD INTRAVENOUS ROUTE. ENDPOINTS OF NUMBER AND TYPE OF ARRHYTHMIAS, XYLOCAINE DOSE, PLASMA, AND MYOCARDIAL XYLOCAINE CONCENTRATIONS WILL BE DETERMINED. THE DEMONSTRA-TION OF THE HYPOTHESIS THAT RETROVENOUS MYOCARDIAL DRUG DELIVERY IS SUPERIOR TO INTRAVENOUS THERAPY AFTER CORONARY ARTERY OCCLUSION COULD PROVIDE AN EFFECTIVE METHOD FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS.

Principal Investigator:

Jeffrey L Peters
Principal Investigator
8015843232

Business Contact:

Small Business Information at Submission:

Ubtl Inc.
520 Wakara Way Salt Lake City, UT 84108

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No